An Act To Require Full Disclosure of Prescription Drug Marketing Costs LR 0072(02)
Maine Legislature, Session 121, LD 0254
Committee Amendment CA_A_H465 (House)

COMMITTEE AMENDMENT "!),, to H.P. 209, L.D. 254, Bill, "An 
Act To Require Full Disclosure of Prescription Drug Marketing 
Costs" 
Amend the bill in section 1 in that part designated "§2699." 
in subsection 4 in paragraph A in the last line (page 2, line 2 
in 
L.D.) 
by 
inserting 
after 
the 
following: 
"State" 
the 
following: 
except for expenses associated with advertising 
purchased 
for 
a 
regional 
or 
national 
market 
that 
includes 
advertising within the State' 
Further amend the bill in section 1 in that part designated 
"§2699." in subsection 8 in the 4th line (page 3, line 31 in 
L.D.) by striking out the following: 
"$10,000" and inserting in 
its place the following: 
'$1,000' 
Further amend the bill by inserting after section 1 
the 
following: 
'Sec. 2. Report. 
The 
Department of 
Human 'Services 
shall 
report to the joint standing committee of the Legislature having 
jurisdiction over health and human services matters on or before 
January 1, 2005 and on or before July 1, 2005 on the assessment 
of 
fees 
on manufacturers 
and 
labelers of prescription drugs 
pursuant to the Maine Revised Statutes, Title 22, section 2699 
and the use of those fees to support the work of the department 
with regard to the provisions of Title 22, section 2699.' 
Page l-LR0072(2) 
COMMITTEE AMENDMENT 
... e;, 
COMMITTEE AMENDMENT "it" to H.P. 209, L.D. 254 
Further amend the bill in section 2 in the first line (page 
3, line 39 in L.D.) by striking out the following: 
"January" and 
inserting in its place the following: 
'July' 
Further amend the 
nonconsecutive 
Part 
consecutively. 
bill by relettering 
letter 
or 
section 
SUMMARY 
or renumber ing any 
number 
to 
read 
This 
amendment 
exempts 
from 
the 
reporting 
requirements 
advertising purchased for a regional or national market, changes 
the fine from $10,000 to $1,000 and changes the effective date to 
July 
1, 
2004. 
The 
amendment 
adds 
a 
requirement 
that 
the 
Department 
of 
Human 
Services 
report 
to 
the 
joint 
standing 
committee of the Legislature having jurisdiction over health and 
human services matters by January 1, 
2005 
and July 1, 
2005 
regarding assessment of fees on prescription drug manufacturers 
and labelers and the use of those fees to support the work of the 
department. 
FISCAL NOTE REQUIRED 
(See attached) 
COMMITTEE AMENDMENT 
Approved: 04/23/03 ;tJk.?ac:.. 
Office of Fiscal and Program Review 
LD254 
An Act To Require Full Disclosure of Prescription Drug Marketing 
Costs 
LR 0072(02) 
Fiscal Note for Bill as Amended by Committee Amendment" " 
Committee: Health and Human Services 
Fiscal Note Required: Yes 
Fiscal Note 
Undetermined current biennium cost increase - Other Special Revenue Funds 
Undetermined current biennium revenue increase - Other Special Revenue Funds 
Minor cost increase - General Fund 
Minor revenue increase - General Fund 
Correctional and Judicial Impact Statements 
Establishes new civil violation 
Fiscal Detail and Notes 
Any initial start-up costs to the Bureau of Medical Services in the Department of Human Services can be absorbed 
within existing budgeted resources. The bill requires prescription drug manufacturers pay fees to the Department in 
addition to submitting reports. The amount of these fees are to be determined by the Department. The timing and 
amount of revenue collected from these fees, as well as the ongoing costs of the Department can not be determined at 
this time. The bill assumes the fees will be sufficient to cover additional costs to the Department. Any additional 
costs to the Office of the Attorney General can be absorbed within existing budgeted resources. 
LR0072(2) - Fiscal Note - Page 1 of 1